Connor Daniel F, Carlson Gabrielle A, Chang Kiki D, Daniolos Peter T, Ferziger Reuven, Findling Robert L, Hutchinson Janice G, Malone Richard P, Halperin Jeffrey M, Plattner Belinda, Post Robert M, Reynolds Diane L, Rogers Kenneth M, Saxena Kirti, Steiner Hans
Department of Psychiatry/MC1410, University of Connecticut Health Center, Farmington 06030-1410, USA.
J Clin Psychiatry. 2006 May;67(5):808-20.
To review prevention programs, psychosocial and psychopharmacologic treatments, and service delivery configurations for children and adolescents with maladaptive aggression. To propose a research agenda for disorders of aggression in child and adolescent psychiatry.
Recent empirical studies were reviewed using searches of MEDLINE and PsycINFO (text terms: aggression, antisocial, violence, conduct, oppositional, psychosocial treatment, psychopharmacology, and prevention), relevant books, review articles, and bibliographies.
Articles met the following criteria: published in an English-language, peer-reviewed journal between 1980 and 2005, included a focus on individuals < 18 years old, and included an outcome measure of relevant significance.
Results of 154 randomized, controlled psychosocial treatment trials, 20 controlled psychopharmacology studies, 4 open-label medication studies, and 2 psychopharmacology meta-analyses were reviewed.
Prevention programs show promise for reducing future aggression in at-risk populations. Empirical support is available for the effectiveness of multifocused psychosocial treatments in reducing aggression in children and adolescents. Atypical antipsychotics, lithium, divalproex sodium, and stimulants for conduct problems associated with attention-deficit/hyperactivity disorder have empirical support for reducing aggression in selected patient populations.
Therapeutic nihilism in the treatment of aggressive children and adolescents with conduct problems is no longer warranted. Multifocused psychosocial interventions given early in life to at-risk children have the most support for effectiveness. However, treatments for children who routinely present to the child psychiatrist with already well-established disorders of aggression are neither robust nor well-established. Further research into maladaptive aggression in referred children and adolescents within and across psychiatric diagnoses is important for the field of child and adolescent psychiatry.
回顾针对具有适应不良性攻击行为的儿童和青少年的预防项目、心理社会及精神药物治疗,以及服务提供模式。提出儿童和青少年精神病学中攻击行为障碍的研究议程。
通过检索MEDLINE和PsycINFO(检索词:攻击、反社会、暴力、品行、对立违抗、心理社会治疗、精神药理学、预防)、相关书籍、综述文章及参考文献,对近期实证研究进行了回顾。
文章符合以下标准:发表于1980年至2005年间的英文、同行评审期刊,聚焦于18岁以下个体,并包含具有相关意义的结局指标。
回顾了154项随机对照心理社会治疗试验、20项对照精神药理学研究、4项开放标签药物研究及2项精神药理学荟萃分析的结果。
预防项目有望减少高危人群未来的攻击行为。有实证支持多焦点心理社会治疗对减少儿童和青少年攻击行为的有效性。非典型抗精神病药物、锂盐、丙戊酸钠以及用于治疗与注意缺陷多动障碍相关品行问题的兴奋剂,在特定患者群体中对减少攻击行为有实证支持。
在治疗有品行问题的攻击性儿童和青少年时,治疗虚无主义已不再合理。在生命早期对高危儿童进行多焦点心理社会干预最具有效性支持。然而,对于经常就诊于儿童精神科医生且攻击行为障碍已确立的儿童的治疗,既不充分也不完善。对转诊的儿童和青少年在精神科诊断内及跨诊断的适应不良性攻击行为进行进一步研究,对儿童和青少年精神病学领域很重要。